BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36201435)

  • 1. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
    Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S
    PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 36165341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Neutrophil-to-Lymphocyte Ratio and the Platelet-to-Lymphocyte Ratio as Predictors of Mortality in Older Adults Hospitalized with COVID-19 in Peru.
    Ortega-Rojas S; Salazar-Talla L; Romero-Cerdán A; Soto-Becerra P; Díaz-Vélez C; Urrunaga-Pastor D; Maguiña JL
    Dis Markers; 2022; 2022():2497202. PubMed ID: 35937941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-Lymphocyte Ratio and Cut-off Values as Predictor of Severity and Mortality in COVID-19 Patients in Millennium COVID-19 Care Center, Addis Ababa, Ethiopia.
    Tadesse Z; Bekele Bayissa A; Diriba T; Chernet N; Tsegaye S; Tsega M
    Int J Gen Med; 2022; 15():6739-6755. PubMed ID: 36039306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.
    Leulseged TW; Hassen IS; Ayele BT; Tsegay YG; Abebe DS; Edo MG; Maru EH; Zewde WC; Naylor LK; Semane DF; Dresse MT; Tezera BB
    PLoS One; 2021; 16(3):e0246087. PubMed ID: 33720944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
    Yao C; Liu X; Tang Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study.
    Zeng ZY; Feng SD; Chen GP; Wu JN
    BMC Infect Dis; 2021 Jan; 21(1):80. PubMed ID: 33461497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.
    Yan X; Li F; Wang X; Yan J; Zhu F; Tang S; Deng Y; Wang H; Chen R; Yu Z; Li Y; Shang J; Zeng L; Zhao J; Guan C; Liu Q; Chen H; Gong W; Huang X; Zhang YJ; Liu J; Dong X; Zheng W; Nie S; Li D
    J Med Virol; 2020 Nov; 92(11):2573-2581. PubMed ID: 32458459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Neutrophil-Lymphocyte Ratio (NLR) as an Indicator of Disease Severity and Prognostic Marker among Patients with Covid-19 Infection in a Tertiary Care Centre in Bangalore - A Retrospective Study.
    PrakashRao VV
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.
    Kilercik M; Demirelce Ö; Serdar MA; Mikailova P; Serteser M
    PLoS One; 2021; 16(8):e0254073. PubMed ID: 34351940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography.
    Arbel Y; Finkelstein A; Halkin A; Birati EY; Revivo M; Zuzut M; Shevach A; Berliner S; Herz I; Keren G; Banai S
    Atherosclerosis; 2012 Dec; 225(2):456-60. PubMed ID: 23040448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism.
    Telo S; Kuluöztürk M; Deveci F; Kirkil G
    Int Angiol; 2019 Feb; 38(1):4-9. PubMed ID: 30618227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Diagnostic Values of the Neutrophil-to-Lymphocyte Ratio (NLR) and Systematic Immunoinflammatory Index (SII) as Biomarkers in Predicting COVID-19 Severity: A Multicentre Comparative Study.
    Sayed AA
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19.
    Fouad SH; Allam MF; Taha SI; Okba AA; Hosny A; Moneer M; Roman SW
    J Int Med Res; 2021 Jul; 49(7):3000605211030124. PubMed ID: 34250826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the neutrophil-to-lymphocyte ratio as an indicator for early referral of patients with COVID-19 pneumonia to a high-care facility.
    Retief CA; Retief HJ; Van der Merwe S
    S Afr Med J; 2022 Oct; 112(10):795-799. PubMed ID: 36472334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
    Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
    Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.